← Back to guidelines
Cardiology16 papers

Hemobilia

Last edited: 4/16/2026

Overview

Hemobilia is a rare but severe condition characterized by bleeding into the biliary tree, often presenting as upper gastrointestinal hemorrhage. It can result from various causes including hepatic artery aneurysms, biliary tract trauma, or iatrogenic injury. 1

Diagnosis

  • Key Diagnostic Criteria: Upper gastrointestinal bleeding with bile in the gastric aspirate or nasogastric tube.
  • Recommended Tests: Emergency celiac and selective hepatic artery angiography.
  • Imaging Findings: Hepatic artery pseudoaneurysms, cystic artery pseudoaneurysms, diffuse hemorrhage of hepatic artery branches, or bile duct fistulae. 1
  • Management

  • First-Line Treatment: Transarterial embolization using Gelfoam particles and/or coils to occlude the bleeding vessel.
  • Targeted Embolization: Embolization of the hepatic artery branch proximal to the bleeding point.
  • Rebleeding Management: Repeat embolization for recurrent bleeding if necessary. 1
  • Special Populations

  • No Specific Data Provided: The abstracts do not cover management specifics for pregnancy, pediatrics, elderly patients, or comorbidities. 1
  • Key Recommendations

  • Perform emergency selective hepatic angiography for rapid diagnosis and treatment in cases of massive hemobilia. (Evidence: Moderate) 1
  • Initiate transarterial embolization as the first-line intervention to control bleeding in hemobilia. (Evidence: Strong) 1
  • Consider repeat embolization if rebleeding occurs post-initial treatment. (Evidence: Weak) 1
  • References

    1 Xu ZB, Zhou XY, Peng ZY, Xu SL, Ruan LX. Evaluation of selective hepatic angiography and embolization in patients with massive hemobilia. Hepatobiliary & pancreatic diseases international : HBPD INT 2005. link

    Original source

    1. [1]
      Evaluation of selective hepatic angiography and embolization in patients with massive hemobilia.Xu ZB, Zhou XY, Peng ZY, Xu SL, Ruan LX Hepatobiliary & pancreatic diseases international : HBPD INT (2005)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG